Clinical trial NCT06796608: Behavioral Activation-Led Activity Engagement for Cancer Empowerment
Official title: Technology-Supported Behavioral Activation to Optimize Day-to-Day Quality of Life With Advanced Cancer
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Advanced Cancer
Cancer
Keywords: behavioral activation
quality of life
Lead sponsor: University of Pittsburgh
Sponsor class: OTHER
First posted: 2025-01-28
Enrollment: 22
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: The goal of this study is to learn if behavioral activation can improve daily quality of life for patients with advanced cancer. The main questions it aims to answer are:

* Can behavioral activation be adapted to help patients living with advanced cancer optimize their daily quality of life?
* Can behavioral activation be delivered primarily via smartphone?

Participants will:

* Complete a demographic questionnaire at the beginning of the study and quality-of-life and activity questionnaires at the beginning, midpoint, and end of study. Complete nightly surveys about daily quality of life, mood, activities, and experiences.
* Wear a Fitbit activity tracker for 8 weeks.
* After the first four weeks, they will complete a session with a member of our team about their day-to-day activities, behaviors, and experiences. They will select at least 4 activities/behaviors to increase over the next portion of the study.
* Incorporate personalized meaningful activities into daily life
* At the end of approximately eight weeks, (four weeks after the session with a study team member), they will complete a semi-structured interview.

Detailed description: Participants (n=25) will be recruited from UPMC Hillman clinics.

Part 1 (Consent and Baseline data collection from weeks 1 to 4):

If eligible patients consent to participate, they will complete online baseline questionnaires. Participant's medical records will be reviewed to extract demographic information and clinical covariates, including information about their cancer, its treatment, biological variables such as sex and age, clinical variables such as comorbidities, surgeries and hospitalizations, medications, and other markers of health care utilization (e.g., emergency department visits). Once extracted, these values will be linked only to their study ID number.

At the initial visit (either in-person or online, 20-30 minutes), participants will also be oriented to the ecological momentary assessment procedures to assess self-reported daily quality of life and mood, activities, and experiences. Participants will install the BALANCE Android or iOS application on their smartphones. The participant ID will be entered into the app upon initial log in and will be saved locally on the device. Participants will have the opportunity to add additional activities to track for 2 days before the 4 weeks of Part 1 of the study begins. When participants receive the survey notification, it will open the application and they can proceed to take the survey in the BALANCE app on their smartphone. Participants will be asked to complete the EMA questions once each evening (approximately 5 minutes). Participants will be able to use the BALANCE app to access visualizations of their past survey responses and quality of life ratings along with activity and sleep data.

Participants will also be asked to wear a Fitbit device (Fitbit Inspire 3 or similar) for the duration of the study and to install the Fitbit app on their smartphone. The Fitbit is a wristwatch-sized waterproof device that assesses heart and breathing rates, physical activity, and sleep, skin temperature, and oxygen levels and wirelessly transmits data to the server. If they already own a Fitbit device, we will request access to their Fitbit data for the duration of their study participation.

Mid-Study Data Review (mid-study data review session following first 4 weeks of the study):

Participants will complete a mid-study data review session (in person or remotely, 20-30 minutes) with a member of our team during which they will be asked which activities, behaviors, and experiences they believe to be the most strongly related to their day-to-day quality of life. They will also be provided with the results of personalized analyses visualizing the factors most strongly correlated with their quality of life ratings over the past four weeks. Based on their own reflections and these personalized analyses, they will be asked to select at least 4 behaviors or activities to increase over the next four weeks. Participants will also complete a midpoint questionnaire at this time.

Part 2 (Data-based intervention from mid-study data review session to approximately 8 weeks):

For the second four weeks of the study, starting after the mid-study data review session with a study team member, participants will complete a morning survey to make a plan for behavior change, receive daily reminders to complete their planned activities through the BALANCE Android or iOS application on their smartphones, and will complete an evening survey to report their daily quality of life and indicate completed activities (both \< 5 minutes) each day. Participants will also collect Fitbit data during the same period. At the end of this second 4-week period, we will invite participants for a 1-on-1 in-person or online semi-structured interview (20-30 minutes) to provide feedback. In addition, we will assist participants in removing the BALANCE app from their phones. Participants will also complete an end of study questionnaire at this time.

Eligibility criteria: Inclusion Criteria:

* diagnosed with Stage IV cancer and receiving ongoing treatment at a UPMC Hillman Cancer Center clinic
* owns and uses a smartphone capable of running study applications

Exclusion Criteria:

* Unable to read, write, or communicate in English

Primary outcomes:
measure: Acceptability
timeFrame: At end of intervention at approximately 8 weeks
measure: Acceptability
timeFrame: At the end of intervention at approximately 8 weeks
measure: Feasibility
timeFrame: From enrollment to the end of intervention at approximately 8 weeks
measure: Feasibility
timeFrame: From enrollment to the end of intervention at approximately 8 weeks
measure: Feasibility
timeFrame: From enrollment to the end of intervention at approximately 8 weeks
Secondary outcomes:
measure: Daily ratings
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
measure: Quality of Life
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
measure: Depressive symptoms
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
Other outcomes:
measure: Restorative Activities
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
measure: Objective physical activity
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
measure: Activity disruption
timeFrame: Change from baseline to the end of intervention at approximately 8 weeks
Locations:
city: Pittsburgh
country: United States
facility: UPMC Hillman Cancer Center
state: Pennsylvania
Study officials:
affiliation: University of Pittsburgh
name: Carissa A Low, PhD
role: PRINCIPAL_INVESTIGATOR
References: